Logo image of GBT.PA

GUERBET (GBT.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:GBT - FR0000032526 - Common Stock

14.16 EUR
-0.26 (-1.8%)
Last: 1/19/2026, 5:26:29 PM
Fundamental Rating

4

Overall GBT gets a fundamental rating of 4 out of 10. We evaluated GBT against 67 industry peers in the Health Care Equipment & Supplies industry. GBT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GBT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • GBT had positive earnings in the past year.
  • GBT had a positive operating cash flow in the past year.
  • Of the past 5 years GBT 4 years were profitable.
  • GBT had a positive operating cash flow in each of the past 5 years.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • GBT's Return On Assets of 0.76% is on the low side compared to the rest of the industry. GBT is outperformed by 61.19% of its industry peers.
  • Looking at the Return On Equity, with a value of 2.06%, GBT is doing worse than 61.19% of the companies in the same industry.
  • GBT has a Return On Invested Capital of 3.15%. This is in the lower half of the industry: GBT underperforms 65.67% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GBT is significantly below the industry average of 9.84%.
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROIC 3.15%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • GBT has a Profit Margin of 0.96%. This is in the lower half of the industry: GBT underperforms 61.19% of its industry peers.
  • In the last couple of years the Profit Margin of GBT has declined.
  • The Operating Margin of GBT (4.19%) is worse than 65.67% of its industry peers.
  • GBT's Operating Margin has declined in the last couple of years.
  • GBT's Gross Margin of 78.03% is amongst the best of the industry. GBT outperforms 91.04% of its industry peers.
  • In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
Industry RankSector Rank
OM 4.19%
PM (TTM) 0.96%
GM 78.03%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBT is destroying value.
  • GBT has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, GBT has more shares outstanding
  • The debt/assets ratio for GBT is higher compared to a year ago.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • GBT has an Altman-Z score of 2.06. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GBT has a Altman-Z score (2.06) which is comparable to the rest of the industry.
  • GBT has a debt to FCF ratio of 8.94. This is a slightly negative value and a sign of low solvency as GBT would need 8.94 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 8.94, GBT perfoms like the industry average, outperforming 43.28% of the companies in the same industry.
  • A Debt/Equity ratio of 0.93 indicates that GBT is somewhat dependend on debt financing.
  • The Debt to Equity ratio of GBT (0.93) is worse than 77.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.94
Altman-Z 2.06
ROIC/WACC0.45
WACC7.02%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
  • GBT has a Current ratio of 2.32. This is in the better half of the industry: GBT outperforms 70.15% of its industry peers.
  • GBT has a Quick Ratio of 1.03. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, GBT is in line with its industry, outperforming 47.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.03
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

  • GBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.27%.
  • The earnings per share for GBT have been decreasing by -15.50% on average. This is quite bad
  • Looking at the last year, GBT shows a decrease in Revenue. The Revenue has decreased by -2.01% in the last year.
  • Measured over the past years, GBT shows a small growth in Revenue. The Revenue has been growing by 0.59% on average per year.
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%

3.2 Future

  • The Earnings Per Share is expected to decrease by -5.56% on average over the next years.
  • The Revenue is expected to grow by 3.86% on average over the next years.
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

  • GBT is valuated rather expensively with a Price/Earnings ratio of 23.60.
  • Based on the Price/Earnings ratio, GBT is valued a bit cheaper than 73.13% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.38, GBT is valued at the same level.
  • GBT is valuated reasonably with a Price/Forward Earnings ratio of 9.69.
  • Based on the Price/Forward Earnings ratio, GBT is valued cheaper than 91.04% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, GBT is valued rather cheaply.
Industry RankSector Rank
PE 23.6
Fwd PE 9.69
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 95.52% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.01
EV/EBITDA 3.95
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • GBT's earnings are expected to decrease with -10.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%

4

5. Dividend

5.1 Amount

  • GBT has a Yearly Dividend Yield of 2.69%.
  • Compared to an average industry Dividend Yield of 0.95, GBT pays a better dividend. On top of this GBT pays more dividend than 89.55% of the companies listed in the same industry.
  • GBT's Dividend Yield is a higher than the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

  • The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 81.59% of the earnings are spent on dividend by GBT. This is not a sustainable payout ratio.
  • The Dividend Rate of GBT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP81.59%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (1/19/2026, 5:26:29 PM)

14.16

-0.26 (-1.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-23
Earnings (Next)02-05
Inst Owners10.22%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap178.98M
Revenue(TTM)809.67M
Net Income(TTM)7.73M
Analysts44
Price Target13.26 (-6.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.59%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.75%
PT rev (3m)-28.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.9%
Revenue NY rev (3m)-1.07%
Valuation
Industry RankSector Rank
PE 23.6
Fwd PE 9.69
P/S 0.22
P/FCF 4.01
P/OCF 1.91
P/B 0.48
P/tB 0.65
EV/EBITDA 3.95
EPS(TTM)0.6
EY4.24%
EPS(NY)1.46
Fwd EY10.32%
FCF(TTM)3.53
FCFY24.91%
OCF(TTM)7.4
OCFY52.27%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.04
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROCE 4.45%
ROIC 3.15%
ROICexc 3.64%
ROICexgc 4.3%
OM 4.19%
PM (TTM) 0.96%
GM 78.03%
FCFM 5.51%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.94
Debt/EBITDA 3.27
Cap/Depr 66.71%
Cap/Sales 6.05%
Interest Coverage 1.56
Cash Conversion 87.13%
Profit Quality 576.4%
Current Ratio 2.32
Quick Ratio 1.03
Altman-Z 2.06
F-Score5
WACC7.02%
ROIC/WACC0.45
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.27%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%
EBIT growth 1Y-42.07%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year50.63%
EBIT Next 3Y21.02%
EBIT Next 5Y21.78%
FCF growth 1Y182.18%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2940.2%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%

GUERBET / GBT.PA FAQ

What is the fundamental rating for GBT stock?

ChartMill assigns a fundamental rating of 4 / 10 to GBT.PA.


What is the valuation status of GUERBET (GBT.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to GUERBET (GBT.PA). This can be considered as Fairly Valued.


How profitable is GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a profitability rating of 3 / 10.


What is the financial health of GUERBET (GBT.PA) stock?

The financial health rating of GUERBET (GBT.PA) is 4 / 10.


Is the dividend of GUERBET sustainable?

The dividend rating of GUERBET (GBT.PA) is 4 / 10 and the dividend payout ratio is 81.59%.